Kirin completes partial business transfer of Kyowa Hakko Bio

Kirin Holdings Co., Ltd. (TSE:2503) announced today the completion of the partial business transfer of its subsidiary, Kyowa Hakko Bio, as initially disclosed on November 22, 2024. The transfer involves Kyowa Hakko Bio's amino acid and human milk oligosaccharide business to a special purpose company that is a subsidiary of Meihua Holdings Group Co., Ltd, a major Chinese bio-industry company. The transaction, previously expected to conclude in the fourth quarter of 2025, was finalized on July 1, 2025. The impact of this business transfer on Kirin Holdings' consolidated financial results for the fiscal year ending December 2025 is currently being assessed, and further details will be disclosed promptly if necessary.